Edinburgh, United Kingdom

Nicholas Turner


Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2002-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Nicholas Turner: Innovator in Enzymatic Deracemization

Introduction

Nicholas Turner is a distinguished inventor based in Edinburgh, GB. He has made significant contributions to the field of enzymatic processes, particularly in the deracemization of chiral amines. With a total of 4 patents to his name, Turner has established himself as a key figure in innovative chemical methodologies.

Latest Patents

One of Turner's latest patents focuses on the deracemization of amines. This invention relates to a method for the chiral inversion of chiral amines through enzymatic treatment. The method employs a stereoselective enzymatic conversion alongside either a non-selective or partially selective chemical or enzymatic conversion, which can occur simultaneously or sequentially. Additionally, the invention outlines a method for selecting suitable enzymes, particularly amine oxidases, and for generating novel enzymes that can be utilized in the deracemization process. Another notable patent involves modified peptide derivatives, which are defined by a specific compound formula as detailed in the patent specification.

Career Highlights

Throughout his career, Nicholas Turner has worked with prominent companies such as Glaxo Group Limited and Cyclacel Limited. His experience in these organizations has contributed to his expertise in the field of enzymatic chemistry and innovation.

Collaborations

Turner has collaborated with notable colleagues, including Marina Victorovna Alexeeva and Alexis Enright. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Nicholas Turner is a prominent inventor whose work in enzymatic deracemization has paved the way for advancements in chemical processes. His patents reflect a commitment to innovation and collaboration in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…